Peripheral Neuropathy Trial, Recruiting NCT07373808 Sponsor: Universidad Complutense de Madrid Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07373808
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have low back pain that spreads down the leg (like sciatica) with a nerve-pain quality, confirmed by a score of 12 or more on a specific nerve pain screening tool called the S-LANSS
  • People whose low back and leg pain has been ongoing for more than 6 months
  • People aged between 18 and 70 years
  • People whose pain in the past 4 weeks has been bad enough to limit their usual activities or change their daily routine for more than one day
  • People who have had at least one period of 6 months to a year during which their pain never fully went away for a whole month
  • People whose pain rates at least 3 out of 10 on a standard pain scale
  • People who are able to give their informed agreement to take part in the study

Who may not be able to join:

  • People with a recent sudden injury or major physical trauma
  • People who have significant pain coming from the hip joint or the pelvic/sacroiliac area (the joints at the base of the spine)
  • People with symptoms that may suggest a serious spinal condition affecting bladder or bowel control, sexual function, or causing leg weakness or paralysis (confirm with trial site)
  • People who have had surgery on the spine, pelvis, or hip at any point
  • People who have received injections with anaesthetic or anti-inflammatory medications, or a procedure called radiofrequency treatment, in the spine or surrounding areas within the past two years
  • People with a neurological or whole-body (systemic) illness that could affect their ability to participate
  • People who are not able to communicate in Spanish or understand the study instructions and materials
  • People for whom certain hands-on or electrical physical therapy techniques would not be medically appropriate (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Complutense de Madrid
Registry
ClinicalTrials.gov
Start date
13 May 2026
Est. completion
1 January 2027

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Pain intensity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov